Portal de Periódicos da CAPES

Efficacy of high‐intensity aerobic exercise on common multiple sclerosis symptoms

2021; Wiley; Volume: 145; Issue: 2 Linguagem: Inglês

10.1111/ane.13540

1600-0404

Martin Langeskov‐Christensen, Lars G. Hvid, Henrik Boye Jensen, Helle Hvilsted Nielsen, Thor Petersen, Egon Stenager, Ulrik Dalgas,

Systemic Sclerosis and Related Diseases

Objectives Fatigue and walking impairment are disabling symptoms of multiple sclerosis (MS). We investigated the effects of progressive aerobic exercise (PAE) on fatigue, walking, cardiorespiratory fitness (VO2max), and quality of life in people with MS (pwMS). Materials & Methods Randomized controlled trial (1:1 ratio, stratified by sex) with a 24-week crossover follow-up and intention-to-treat analysis. Allocation to an exercise (24 weeks of PAE followed by self-guided physical activity) and a waitlist (24 weeks of habitual lifestyle followed by PAE) group. PAE comprised two supervised sessions per week; 30–60 min, 65–95% of maximum heart rate. Fatigue impact (Modified Fatigue Impact Scale; MFIS) and severity (Fatigue Severity Scale; FSS), walking ability (12-item MS Walking Scale; MSWS-12) and capacity (Six-Minute Walk Test; 6MWT, Six Spot Step Test; SSST), quality of life (Short Form 36 health survey; SF-36), and VO2max were measured at baseline, 24 weeks, and 48 weeks. Results Eighty-six pwMS were enrolled. Following PAE between-group differences showed reductions in MFIStotal (−5.3 [95% CI: −10.9;0.4], point estimate >clinical relevance), MFISphysical subscore (−2.8 [−5.6;-0.1]), and MFISpsychosocial subscore (−0.9 [−1.6;-0.2]), and an increase in VO2max (+3.5 ml O2/min/kg [2.0;5.1]). MSWS-12 (−5.9 [−11.9; 0.2]) and 6MWT (+14 m [−5;33]) differences suggested potential small walking improvements. No changes observed in FSS, SSST, or SF-36. Conclusions In a representative sample of pwMS, PAE induced a clinically relevant reduction in fatigue impact, whereas small and no effects were seen for walking and quality of life, respectively. The results need confirmation in a future trial due to the study limitations.